XENE icon

Xenon Pharmaceuticals
XENE

Overview Fund Activity

25 hedge funds and large institutions have $45.2M invested in Xenon Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
-1
Holders Change %
-3.85%
% of All Funds
0.7%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
5
Increased
7
Reduced
9
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Capital World Investors
1
Capital World Investors
California
$8.51M
2
BI
2
BVF Inc
California
$8.55M
3
OM
3
Opaleye Management
Massachusetts
$1.25M
4
JC
4
JBF Capital
Colorado
$567K
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$2.62M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$7.52M
2
EC
2
EcoR1 Capital
California
$0
3
GTC
3
Ghost Tree Capital
New York
$0
4
Renaissance Technologies
4
Renaissance Technologies
New York
$169K
5
PA
5
Perceptive Advisors
New York
$1.7M
Name Holding Trade Value Shares
Change 		Shares
Change %
EC
26
EcoR1 Capital
California
– -$842K -73,000 Closed
GTC
27
Ghost Tree Capital
New York
– -$432K -37,500 Closed
SIM
28
Spark Investment Management
New York
– -$118K -10,300 Closed
Morgan Stanley
29
Morgan Stanley
New York
– -$33K -2,829 Closed
PCM
30
Prelude Capital Management
New York
– -$30K -2,600 Closed
UBS Group
31
UBS Group
Switzerland
– -$12K -1,058 Closed
1
2